174 related articles for article (PubMed ID: 25179571)
1. Splenectomy modifies hyperactive states of the dopaminergic system induced by morphine in C57BL/6J-bg(J)/bg(J) (beige-J) mice.
Funada M; Mori T; Maeda J; Tsuda Y; Komiya S; Shimizu N; Kamei J; Suzuki T
Eur J Pharmacol; 2014 Nov; 742():89-93. PubMed ID: 25179571
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic hyperactivity accompanied by hyperlocomotion in C57BL/6J-bg(J)/bg(J) (beige-J) mice.
Mori T; Funada M; Tsuda Y; Maeda J; Uchida M; Suzuki T
J Pharmacol Sci; 2014; 125(2):233-6. PubMed ID: 24881959
[TBL] [Abstract][Full Text] [Related]
3. Complicated interaction between psychostimulants and morphine in expression of phenotype of behavior in the dopaminergic system of BALB/c mice.
Ito S; Mori T; Namiki M; Suzuki T; Sawaguchi T
J Pharmacol Sci; 2007 Dec; 105(4):326-33. PubMed ID: 18057777
[TBL] [Abstract][Full Text] [Related]
4. Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice.
Narita M; Suzuki T; Funada M; Misawa M; Nagase H
Psychopharmacology (Berl); 1993; 111(4):423-6. PubMed ID: 7870983
[TBL] [Abstract][Full Text] [Related]
5. The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J: Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates.
Raffa RB; Kimball ES; Mathiasen JR
Life Sci; 1988; 42(12):1231-6. PubMed ID: 3347148
[TBL] [Abstract][Full Text] [Related]
6. Obligatory role of B cells and adherent accessory cells in the transfer of a defect in morphine-mediated antinociception in C57BL/6J-bg/bg (beige-J) mice.
Kimball ES; Raffa RB
J Neuroimmunol; 1989 May; 22(3):185-92. PubMed ID: 2784797
[TBL] [Abstract][Full Text] [Related]
7. Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice.
Narita M; Shibasaki M; Mizuo K; Suzuki T
Addict Biol; 2003 Sep; 8(3):319-25. PubMed ID: 13129834
[TBL] [Abstract][Full Text] [Related]
8. Genetic influences on drug-induced psychomotor activation in mice.
Gill KJ; Boyle AE
Genes Brain Behav; 2008 Nov; 7(8):859-68. PubMed ID: 19076633
[TBL] [Abstract][Full Text] [Related]
9. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
Hofford RS; Wellman PJ; Eitan S
J Psychopharmacol; 2012 Oct; 26(10):1355-65. PubMed ID: 22522973
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
11. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity.
Kaplan GB; Leite-Morris KA; Klufas MA; Fan W
Eur J Pharmacol; 2009 Jan; 602(2-3):268-76. PubMed ID: 19027733
[TBL] [Abstract][Full Text] [Related]
12. Studies on the role of dopaminergic systems in morphine-induced motor activity. Comparison with noradrenergic and cholinergic systems.
VanderWende C; Spoerlein MT; Can Luc N
Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):79-88. PubMed ID: 1153864
[TBL] [Abstract][Full Text] [Related]
13. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Jentsch JD; Taylor JR; Roth RH
Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
[TBL] [Abstract][Full Text] [Related]
14. Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function.
Spanagel B; Stöhr T; Barden N; Holsboer F
J Neuroendocrinol; 1996 Feb; 8(2):93-7. PubMed ID: 8868255
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice.
Kamei J; Saitoh A
Life Sci; 1997; 60(19):1699-708. PubMed ID: 9129125
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice.
Airavaara M; Tuomainen H; Piepponen TP; Saarma M; Ahtee L
Genes Brain Behav; 2007 Apr; 6(3):287-98. PubMed ID: 16879618
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the K+-Cl- co-transporter KCC2 in the sensitization to morphine-induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system.
Shibasaki M; Masukawa D; Ishii K; Yamagishi Y; Mori T; Suzuki T
J Neurochem; 2013 Jun; 125(5):747-55. PubMed ID: 23565710
[TBL] [Abstract][Full Text] [Related]
18. Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics.
Mori T; Iwase Y; Murata A; Iwata N; Suzuki T
Behav Brain Res; 2016 Jun; 306():64-70. PubMed ID: 26992824
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive defect of beige-J mice reversed by i.c.v. IP3 or myo-inositol.
Raffa RB; Martinez RP
Neuroreport; 1995 Jul; 6(10):1434-6. PubMed ID: 7488742
[TBL] [Abstract][Full Text] [Related]
20. Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: evidence for the importance of exposure period.
Narita M; Miyagawa K; Mizuo K; Yoshida T; Suzuki T
Addict Biol; 2007 Jun; 12(2):167-72. PubMed ID: 17508988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
